CQ-16
CQ-16 is an orally bioavailable small molecule drug conjugate (SMDC) targeting PSMA with high selectivity for PSMA-positive prostate cancer cells. It also functions as a potent PARP inhibitor (IC50=1 nM), supporting its investigation in targeted therapy and combination strategies for prostate cancer research in both cellular and animal models.
Product Specifications
CAS Number
3024354-59-1
Field of Research
Epigenetics & Chromatin, Immunology & Inflammation, Molecular Biology, Pharmacology & Drug Discovery
Smiles
C (=O) (C1 (NC (CCC (NCCCC[C@H] (NC (N[C@@H] (CCC (O) =O) C (O) =O) =O) C (O) =O) =O) =O) CC1) N2CCN (C (=O) C3=CC (CC=4C=5C (C (=O) NN4) =CC=CC5) =CC=C3F) CC2
Molecular Formula
C40H47FN8O12
Molecular Weight
850.85
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL317354V 500 µL Each
TTC7A Human shRNA Lentiviral Particle (Locus ID 57217)
Sign In for Pricing
View Details 
UAC51488-01 10 mg
2- (Benzyloxy) -4-phenethylisoquinoline-1,3 (2H,4H) -dione
Sign In for Pricing
View Details UAC51488-02 25 mg
2- (Benzyloxy) -4-phenethylisoquinoline-1,3 (2H,4H) -dione
Sign In for Pricing
View Details UAC51488-03 50 mg
2- (Benzyloxy) -4-phenethylisoquinoline-1,3 (2H,4H) -dione
Sign In for Pricing
View Details UAC51488-04 100 mg
2- (Benzyloxy) -4-phenethylisoquinoline-1,3 (2H,4H) -dione
Sign In for Pricing
View Details 
UAC51488-05 250 mg
2- (Benzyloxy) -4-phenethylisoquinoline-1,3 (2H,4H) -dione
Sign In for Pricing
View Details